Literature DB >> 35228951

Epidemiology of Ocular Malignancies Among the Lebanese Population: A 12-Year Review.

Dany Akiki1, Said El Hage2,3, Jad El Masri1,3, Wassef Chanbour4.   

Abstract

Purpose Our article aims to assess the epidemiology of eye cancer in Lebanon and compare it with other regions worldwide and to study its future trends among Lebanese males and females. Methods Data on eye cancer cases from 2005 to 2016 were obtained from the Lebanese National Cancer Registry (NCR). Age-specific rates, crude rates, and age-standardized rates (ASRs) were subsequently calculated. Joinpoint was used to determine the changes in the slope of trends. A projection for the next 14 years was predicted using linear and logarithmic regression models. Results Among all tumors, eye cancer ranked 40 in females and 41 in males. The eye cancer ASR was 0.24 and 0.22 per 100,000 in males and females, respectively. However, the mean age of eye cancer was 31.94 years in males and 22.04 years in females. The cumulative risk between 0 and 74 years was 0.02%. From 2004 till 2016, a negative trend of eye cancer was observed, with a parallelism of trends between males and females. Age-specific rates showed a bimodal distribution in males. The first cluster was witnessed in the age group of 0-4 years and the second one in those above 50. An additional cluster of distribution was observed in females between 35 and 44 years of age. Forecasts for the next 14 years revealed a steady rate of eye cancer incidence of about 0.2 per 100,000. Moreover, Lebanon showed a relatively low eye cancer ASR compared to other regions worldwide, especially Zimbabwe with 5.8 and 4.8 per 100,000 in females and males, respectively. Conclusion Ocular malignancies showed a negative trend of incidence. A 14-year projection predicts a steady incidence rate in Lebanon and worldwide. Eye cancer seems to be affected by many risk factors. Future efforts are needed for a better understanding of the disease and a better outcome.
Copyright © 2022, Akiki et al.

Entities:  

Keywords:  cancer; epidemiology; eye; incidence rate; lebanon

Year:  2022        PMID: 35228951      PMCID: PMC8867964          DOI: 10.7759/cureus.21593

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  23 in total

1.  Uveal melanoma in relation to ultraviolet light exposure and host factors.

Authors:  E A Holly; D A Aston; D H Char; J J Kristiansen; D K Ahn
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

2.  Mortality predictions for colon and anorectal cancer for Ireland, 2003-17.

Authors:  P O'Lorcain; S Deady; H Comber
Journal:  Colorectal Dis       Date:  2006-06       Impact factor: 3.788

3.  Eye cancer incidence in Singapore.

Authors:  S B Lee; K G Au Eong; S M Saw; T K Chan; H P Lee
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

4.  Incidence and prevalence of eye cancer.

Authors:  R N Kleinstein; H F Lehman
Journal:  Am J Optom Physiol Opt       Date:  1977-01

5.  Trends in eye cancer mortality among adults in the USA and England and Wales.

Authors:  A J Foss; P J Dolin
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

Review 6.  Epidemiology of tumors affecting the visual system.

Authors:  E C Marshall
Journal:  Optom Clin       Date:  1993

7.  Patterns of Retinoblastoma in Zimbabwe: 2000-2009.

Authors:  I Chitsike; P Kuona; J Dzangare; D Sibanda; R Masanganise
Journal:  Cent Afr J Med       Date:  2012 Jan-Apr

Review 8.  Disparities in Uveal Melanoma: Patient Characteristics.

Authors:  Erin E Nichols; Ann Richmond; Anthony B Daniels
Journal:  Semin Ophthalmol       Date:  2016-04-29       Impact factor: 1.975

9.  Sample Size Determination for Studies with Repeated Continuous Outcomes.

Authors:  Dulal K Bhaumik; Anindya Roy; Subhash Aryal; Kwan Hur; Naihua Duan; Sharon-Lise T Normand; C Hendricks Brown; Robert D Gibbons
Journal:  Psychiatr Ann       Date:  2008-12-01

10.  Retinoblastoma in Lebanon.

Authors:  E I Traboulsi; F Jurdi-Nuwayhid; G T Frangieh; V M Der Kaloustian
Journal:  Ophthalmic Paediatr Genet       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.